3,4-dihydroxyphenylacetic acid has been researched along with thymidine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambrosio, S; Boada, J; Castaño, E; Francisco, R; Giménez-Xavier, P; Gómez-Santos, C; Sanz, E; Unzeta, M | 1 |
1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and thymidine
| Article | Year |
|---|---|
The decrease of NAD(P)H has a prominent role in dopamine toxicity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Biomarkers; Cell Line, Tumor; Cell Proliferation; Dopamine; Humans; Mitochondria; NADP; Oxygen; Thymidine | 2006 |